Core Insights - The core point of the article is that Jianhe Group reported a significant increase in revenue and market share in the infant formula sector for the first nine months of 2025, indicating strong growth in the company's performance [1] Financial Performance - Jianhe Group achieved a revenue of 10.805 billion yuan for the first nine months of 2025, representing a year-on-year growth of 12.3% [1] - The sales revenue of infant formula in mainland China saw a substantial increase of 35.2% year-on-year during the reporting period [1] Market Position - In the third quarter, the market share of the ultra-premium infant formula brand, He Sheng Yuan, rose to 17.3%, marking a historical high for the company [1] - He Sheng Yuan's infant probiotic nutritional supplements also returned to double-digit growth, reflecting a positive trend in product demand [1]